These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29444279)

  • 1. Adult Brainstem Gliomas With H3K27M Mutation: Radiology, Pathology, and Prognosis.
    Daoud EV; Rajaram V; Cai C; Oberle RJ; Martin GR; Raisanen JM; White CL; Foong C; Mickey BE; Pan E; Hatanpaa KJ
    J Neuropathol Exp Neurol; 2018 Apr; 77(4):302-311. PubMed ID: 29444279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of H3K27M mutation in cases of brain stem subependymoma.
    Yao K; Duan Z; Wang Y; Zhang M; Fan T; Wu B; Qi X
    Hum Pathol; 2019 Feb; 84():262-269. PubMed ID: 30389438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of H3K27M Mutation in "Nonmidline" High-Grade Gliomas of Cerebral Hemispheres.
    La Rocca G; Sabatino G; Altieri R; Signorelli F; Ricciardi L; Gessi M; Della Pepa GM
    World Neurosurg; 2019 Nov; 131():174-176. PubMed ID: 31415896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The H3.3 K27M mutation results in a poorer prognosis in brainstem gliomas than thalamic gliomas in adults.
    Feng J; Hao S; Pan C; Wang Y; Wu Z; Zhang J; Yan H; Zhang L; Wan H
    Hum Pathol; 2015 Nov; 46(11):1626-32. PubMed ID: 26297251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A machine learning-based prediction model of H3K27M mutations in brainstem gliomas using conventional MRI and clinical features.
    Pan CC; Liu J; Tang J; Chen X; Chen F; Wu YL; Geng YB; Xu C; Zhang X; Wu Z; Gao PY; Zhang JT; Yan H; Liao H; Zhang LW
    Radiother Oncol; 2019 Jan; 130():172-179. PubMed ID: 30097251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse midline glioma-H3K27M mutant. A novel entity with a defining and specific IHC marker.
    Agarwal P; Aiyer HM
    Indian J Pathol Microbiol; 2021; 64(2):351-353. PubMed ID: 33851633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological characteristics and prognosis of diffuse midline gliomas with histone H3K27M mutation: an analysis of 30 cases].
    Li HN; Shan CG; Fan CZ; Cheng LN; Wu SG; Liu MT; Jiang GY; Li Z
    Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):192-198. PubMed ID: 30831644
    [No Abstract]   [Full Text] [Related]  

  • 8. Brainstem pilocytic astrocytoma with H3 K27M mutation: case report.
    Morita S; Nitta M; Muragaki Y; Komori T; Masui K; Maruyama T; Ichimura K; Nakano Y; Sawada T; Koriyama S; Tsuzuki S; Yasuda T; Hashimoto K; Niwa A; Kawamata T
    J Neurosurg; 2018 Sep; 129(3):593-597. PubMed ID: 28960151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation.
    Aboian MS; Solomon DA; Felton E; Mabray MC; Villanueva-Meyer JE; Mueller S; Cha S
    AJNR Am J Neuroradiol; 2017 Apr; 38(4):795-800. PubMed ID: 28183840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinico-pathological and molecular characterization of diffuse midline gliomas: is there a prognostic significance?
    Manjunath N; Jha P; Singh J; Raheja A; Kaur K; Suri A; Garg A; Sharma MC; Sarkar C; Mohan M; Mani K; Suri V
    Neurol Sci; 2021 Mar; 42(3):925-934. PubMed ID: 32666407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas.
    Schreck KC; Ranjan S; Skorupan N; Bettegowda C; Eberhart CG; Ames HM; Holdhoff M
    J Neurooncol; 2019 May; 143(1):87-93. PubMed ID: 30864101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H3 K27M-mutant diffuse midline gliomas in different anatomical locations.
    Wang L; Li Z; Zhang M; Piao Y; Chen L; Liang H; Wei Y; Hu Z; Zhao L; Teng L; Lu D
    Hum Pathol; 2018 Aug; 78():89-96. PubMed ID: 29727696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone H3K27M Mutation Overrides Histological Grading in Pediatric Gliomas.
    Mosaab A; El-Ayadi M; Khorshed EN; Amer N; Refaat A; El-Beltagy M; Hassan Z; Soror SH; Zaghloul MS; El-Naggar S
    Sci Rep; 2020 May; 10(1):8368. PubMed ID: 32433577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.
    Karremann M; Gielen GH; Hoffmann M; Wiese M; Colditz N; Warmuth-Metz M; Bison B; Claviez A; van Vuurden DG; von Bueren AO; Gessi M; Kühnle I; Hans VH; Benesch M; Sturm D; Kortmann RD; Waha A; Pietsch T; Kramm CM
    Neuro Oncol; 2018 Jan; 20(1):123-131. PubMed ID: 29016894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes.
    Huang T; Garcia R; Qi J; Lulla R; Horbinski C; Behdad A; Wadhwani N; Shilatifard A; James C; Saratsis AM
    Oncotarget; 2018 Dec; 9(98):37112-37124. PubMed ID: 30647848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas.
    Bechet D; Gielen GG; Korshunov A; Pfister SM; Rousso C; Faury D; Fiset PO; Benlimane N; Lewis PW; Lu C; David Allis C; Kieran MW; Ligon KL; Pietsch T; Ellezam B; Albrecht S; Jabado N
    Acta Neuropathol; 2014 Nov; 128(5):733-41. PubMed ID: 25200321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant.
    Dufour C; Perbet R; Leblond P; Vasseur R; Stechly L; Pierache A; Reyns N; Touzet G; Le Rhun E; Vinchon M; Maurage CA; Escande F; Renaud F
    Brain Pathol; 2020 Jan; 30(1):179-190. PubMed ID: 31348837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone-mutant glioma presenting as diffuse leptomeningeal disease.
    Nadkarni T; Hamilton K; Niazi F; Ward M; Okakpu U; Castellani RJ; Prisneac I; Sener U
    CNS Oncol; 2021 Sep; 10(3):CNS75. PubMed ID: 34469205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas.
    Piunti A; Hashizume R; Morgan MA; Bartom ET; Horbinski CM; Marshall SA; Rendleman EJ; Ma Q; Takahashi YH; Woodfin AR; Misharin AV; Abshiru NA; Lulla RR; Saratsis AM; Kelleher NL; James CD; Shilatifard A
    Nat Med; 2017 Apr; 23(4):493-500. PubMed ID: 28263307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four methods to analyze H3K27M mutation in diffuse midline gliomas.
    Zhao H; Fang X; Xue B
    Pathol Res Pract; 2020 Sep; 216(9):153065. PubMed ID: 32825938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.